Related Experiment Video
Updated: Jul 17, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
[Oncogenetic consultation for breast cancer]
Agnès Chompret1, Catherine Noguès, Dominique Stoppa-Lyonnet
1Institut Gustave Roussy, 94805 Villejuif, France. chompret@igr.fr
Genetic testing for BRCA1 or BRCA2 mutations helps identify hereditary breast and ovarian cancer risks. Early detection and management, including regular screenings and prophylactic surgeries, are crucial for high-risk individuals.
Area of Science:
- Oncology
- Human Genetics
- Cancer Predisposition Syndromes
Context:
- Approximately 5% of breast cancers stem from inherited genetic predispositions.
- BRCA1 and BRCA2 gene mutations significantly elevate the risk of breast and ovarian cancers.
- Oncogenetic consultations are vital for assessing personal and family cancer histories.
Purpose:
- To elucidate the genetic origins of hereditary breast cancer through formal and molecular genetics.
- To guide patient and family management strategies based on genetic findings.
- To identify specific familial genetic alterations using diagnostic genetic tests on index cases.
Summary:
- Diagnostic genetic testing aims to detect mutations in genes like BRCA1/BRCA2, indicating hereditary cancer risk.
- A negative test result does not exclude a predisposition; however, identifying a mutation allows for targeted screening of relatives.
- Management for mutation carriers involves intensive surveillance (clinical exams, annual imaging from age 25-30) and consideration of prophylactic surgeries (mastectomy, adnexectomy).
Impact:
- Identification of BRCA1/BRCA2 mutations enables personalized cancer prevention strategies.
- Early and targeted screening significantly improves outcomes for individuals with hereditary cancer syndromes.
- Prophylactic surgeries can drastically reduce cancer incidence in high-risk populations.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...